Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Aug 8, 2023--

Related Keywords

Denver ,Colorado ,United States ,California ,Ukraine ,Eric Hyllengren ,Pascal Touchon ,Pierre Fabre ,Alex Chapman ,International Society Of Neuroimmunology ,Nasdaq ,Exchange Commission ,Linkedin ,Securities Exchange ,Atara Biotherapeutics Inc ,Chief Executive Officer ,Post Transplant Lymphoproliferative Disease ,Progressive Multiple Sclerosis ,International Society ,Glial Fibrillary Acidic Protein ,Investigational New Drug Application ,Bayer Collaboration Agreements ,Securities Act ,Securities Exchange Act ,Southern California ,Financial Condition ,Consolidated Statements ,Comprehensive Income ,Business Wire ,Region ,